(IN BRIEF) Roche has announced positive results from its phase III REGENCY study, showing that its drug Gazyva®/Gazyvaro® (obinutuzumab) significantly outperformed standard therapy in treating active lupus nephritis. The study found that patients receiving Gazyva/Gazyvaro, in combination with standard therapies, … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Switzerland, Technology
Tagged Dr. Brad H. Rovin, Gazyva, kidney disease patients, Levi Garraway, lupus nephritis, Roche, safety
National award for new University of Leicester research into preventing heart disease in dialysis patients Leicester, UK, 10-2-2014 — /EuropaWire/ — A podcast recording of Dr James Burton explaining his new research project is available to embed and download at: http://soundcloud.com/university-of-leicester/james-burton … Read the full press release
Posted in Awards, Education, Healthcare, Science, United Kingdom
Tagged Chronic kidney disease, dialysis patients, Dr James Burton, heart disease, kidney disease patients, National Institute for Health Research (NIHR) Clinician Scientist Award, preventing heart disease in dialysis patients, Professor David Wynford-Thomas, University of Leicester, University of Leicester research
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?